Sandu Pharmaceuticals Limited (BOM:524703)
India · Delayed Price · Currency is INR 38.00
-1.30 (-3.31%)
At close: Jul 28, 2026
Sandu Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 699.35 | 699.35 | 671.92 | 672.81 | 653.49 | 655.01 |
Revenue Growth | 4.08% | 4.08% | -0.13% | 2.96% | -0.23% | 11.48% |
Gross Profit Gross Profit Growth | 383.63 | 383.63 | 329.57 | 326.41 | 320.66 | 276.7 |
Operating Income Operating Income Growth | 23.23 | 23.23 | 20.94 | 17.12 | 19.69 | 23.44 |
Net Income Net Income Growth | 17.66 | 17.66 | 15.52 | 14.61 | 15.21 | 15.89 |
Earnings Per Share EPS Growth | 1.83 | 1.83 | 1.60 | 1.51 | 1.61 | 1.87 |
EPS Growth | 14.37% | 14.37% | 5.96% | -6.21% | -13.90% | 21.43% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 68.56 | 68.56 | 26.53 | 12.06 | 22.96 | 41.71 |
Total Debt Total Debt Growth | 4.19 | 4.19 | 4.78 | 0.63 | - | - |
Net Cash (Debt) Net Cash Growth | 64.37 | 64.37 | 21.76 | 11.43 | 22.96 | 41.71 |
Net Cash Growth | 195.87% | 195.87% | 90.33% | -50.21% | -44.96% | -64.16% |
Net Cash Per Share Net Cash Per Share Growth | 6.67 | 6.67 | 2.25 | 1.18 | 2.43 | 4.91 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 61.16 | 61.16 | 9.48 | 7.6 | 2.21 | 9.49 |
Capital Expenditures CapEx Growth | -7.2 | -7.2 | -9.38 | -14.25 | -10.69 | -8.41 |
Free Cash Flow Free Cash Flow Growth | 53.96 | 53.96 | 0.1 | -6.65 | -8.48 | 1.08 |
Free Cash Flow Growth | 51782.69% | 51782.69% | - | - | - | -98.56% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.85% | 54.85% | 49.05% | 48.51% | 49.07% | 42.24% |
Operating Margin | 3.32% | 3.32% | 3.12% | 2.54% | 3.01% | 3.58% |
Pretax Margin | 3.80% | 3.80% | 3.21% | 3.08% | 3.39% | 3.54% |
Profit Margin | 2.53% | 2.53% | 2.31% | 2.17% | 2.33% | 2.43% |
FCF Margin | 7.72% | 7.72% | 0.01% | -0.99% | -1.30% | 0.16% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.800 | 0.800 | 0.750 | 0.750 |
Dividend Per Share Growth | 0% | 25.00% | 0% | 6.67% | 0% | 50.00% |
Dividend Yield | 2.54% | 3.28% | 1.66% | 1.44% | 1.49% | 1.12% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.77 | 16.70 | 30.50 | 37.94 | 39.01 | 39.00 |
P/FCF Ratio | 6.80 | 5.46 | 4550.88 | - | - | 575.52 |
PS Ratio | 0.52 | 0.42 | 0.70 | 0.82 | 0.91 | 0.95 |